Published March 30, 2012 | Version v1
Journal article Open

The Role of Inflammatory Pathway Genetic Variation on Maternal Metabolic Phenotypes during Pregnancy

Description

Background: Since mediators of inflammation are associated with insulin resistance, and the risk of developing diabetes mellitus and gestational diabetes, we hypothesized that genetic variation in members of the inflammatory gene pathway impact glucose levels and related phenotypes in pregnancy. We evaluated this hypothesis by testing for association between genetic variants in 31 inflammatory pathway genes in the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) cohort, a large multiethnic multicenter study designed to address the impact of glycemia less than overt diabetes on pregnancy outcome.

Results: Fasting, 1-hour, and 2-hour glucose, fasting and 1-hour C-peptide, and HbA1c levels were measured in blood samples obtained from HAPO participants during an oral glucose tolerance test at 24-32 weeks gestation. We tested for association between 458 SNPs mapping to 31 genes in the inflammatory pathway and metabolic phenotypes in 3836 European ancestry and 1713 Thai pregnant women. The strongest evidence for association was observed with TNF alpha and HbA1c (rs1052248; 0.04% increase per allele C; p-value = 4.4×10−5), RETN and fasting plasma glucose (rs1423096; 0.7 mg/dl decrease per allele A; p-value = 1.1×10−4), IL8 and 1 hr plasma glucose (rs2886920; 2.6 mg/dl decrease per allele T; p-value = 1.3×10−4), ADIPOR2 and fasting C-peptide (rs2041139; 0.55 ug/L decrease per allele A; p-value = 1.4×10−4), LEPR and 1-hour C-peptide (rs1171278; 0.62 ug/L decrease per allele T; p-value = 2.4×10−4), and IL6 and 1-hour plasma glucose (rs6954897; −2.29 mg/dl decrease per allele G, p-value = 4.3×10−4).

Conclusion: Based on the genes surveyed in this study the inflammatory pathway is unlikely to have a strong impact on maternal metabolic phenotypes in pregnancy although variation in individual members of the pathway (e.g. RETN, IL8, ADIPOR2, LEPR, IL6, and TNF alpha,) may contribute to metabolic phenotypes in pregnant women.

Files

journal.pone.0032958.pdf

Files (281.4 kB)

Name Size Download all
Article
md5:4f08d2e3cf00c249b53fc377d0c712ed
281.4 kB Preview Download

Additional details

Identifiers

DOI
10.1371/journal.pone.0032958
Other
oai:uchicago.tind.io:8554

Funding

Eunice Kennedy Shrive National Institute of Child and Human Development and the National Institute of Diabetes, Digestive, and Kidney Diseases
R01 DK067459
Eunice Kennedy Shrive National Institute of Child and Human Development and the National Institute of Diabetes, Digestive, and Kidney Diseases
R01-HD34242
Eunice Kennedy Shrive National Institute of Child and Human Development and the National Institute of Diabetes, Digestive, and Kidney Diseases
R01-HD34243
National Center for Research Resources
M01-RR00048
National Center for Research Resources
M01-RR00080
American Diabetes Association
Wellcome Trust
Henry Wellcome Postdoctoral Fellowship
Peninsula NIHR Clinical Research Facility
Diabetes UK
RD04/0002756
Kiaser Permanente Medical Center
KK Women's and Children's Hospital
Mater Mother's Hospital
Novo Nordisk
Royal College of Physicians of Edinburgh
Myre Sim Fund
Howard and Carol Bernick Family Foundation

UChicago Information

Division(s)
Biological Sciences Division
Department(s)
Human Genetics